<code id='CE1C3A8587'></code><style id='CE1C3A8587'></style>
    • <acronym id='CE1C3A8587'></acronym>
      <center id='CE1C3A8587'><center id='CE1C3A8587'><tfoot id='CE1C3A8587'></tfoot></center><abbr id='CE1C3A8587'><dir id='CE1C3A8587'><tfoot id='CE1C3A8587'></tfoot><noframes id='CE1C3A8587'>

    • <optgroup id='CE1C3A8587'><strike id='CE1C3A8587'><sup id='CE1C3A8587'></sup></strike><code id='CE1C3A8587'></code></optgroup>
        1. <b id='CE1C3A8587'><label id='CE1C3A8587'><select id='CE1C3A8587'><dt id='CE1C3A8587'><span id='CE1C3A8587'></span></dt></select></label></b><u id='CE1C3A8587'></u>
          <i id='CE1C3A8587'><strike id='CE1C3A8587'><tt id='CE1C3A8587'><pre id='CE1C3A8587'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:12653
          Tome cofounders Jonathan Gootenberg, left, and Omar Abudayyeh, a scientific team that's trying to reinvent gene editing for a new era of biotech innovation.
          Suzanne Kreiter/Globe staff

          WATERTOWN — Their brainstorming began in an MIT class in 2010 when the eager undergrads shot each other emails about how to solve a bioengineering equation. It has continued for 14 years over sushi dinners, between Marvel movies, and during rowing-machine workouts.

          Together, Omar Abudayyeh, 33, and Jonathan Gootenberg, 32, have probed the mysteries of genomic editing and COVID detection. They co-published 10 scientific papers, helped launch two medical-diagnostic companies, and cofounded a Watertown startup, Tome Biosciences, that reengineers genes and cells to cure diseases. They also run the Abudayyeh-Gootenberg Lab at Harvard.

          advertisement

          Gootenberg and Abudayyeh are an unusual pair, two scientists — a Jewish American and a Palestinian American — who prefer working together in a field that often draws solitary researchers and rewards individual achievement.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In

          explore

          Supreme Court strikes down use of affirmative action
          Supreme Court strikes down use of affirmative action

          ActivistsdemonstratedastheSupremeCourtheardoralargumentsonapairofaffirmativeactioncasesinOctober2022

          read more
          FDA clears Verve to begin U.S. study of gene
          FDA clears Verve to begin U.S. study of gene

          AdobeVerveTherapeuticssaidMondaythatithadreceivedclearancefromtheFoodandDrugAdministrationtoconducta

          read more
          FDA approval of Sarepta Duchenne genetic therapy gives me hope
          FDA approval of Sarepta Duchenne genetic therapy gives me hope

          Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

          read more

          Why you get paid to donate plasma but not blood

          Payingblooddonorsmightleadpeopletoconcealriskybehaviors.JoernPollex/GettyImagesDonatingplasmaanddona